Wolverine Trading
CLPT icon

Wolverine Trading’s ClearPoint Neuro CLPT Stock Holding History

Wolverine Trading’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$317K Buy
+14,702
New +$173K ﹤0.01% 4302
2021
Q3 		– Sell
-20,374
Closed -$384K – 6327
2021
Q2 		$384K Buy
+20,374
New +$394K ﹤0.01% 4080

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return

Wolverine Trading's CLPT Position: Q3 2025 in Review

Wolverine Trading opened a new position in ClearPoint Neuro (CLPT) in Q3 2025: 14,702 shares worth $317K. The stake represents ﹤0.01% of the portfolio and ranks #4302 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in CLPT as recently as Q2 2021.

Wolverine Trading first reported a position in CLPT in Q2 2021 and has held it in 2 quarters since. The position peaked at $384K in Q2 2021. 107 funds tracked by Wall St. Rank hold CLPT as of Q3 2025.

  • Wolverine Trading held 14,702 shares of ClearPoint Neuro worth $317K as of Q3 2025.
  • ClearPoint Neuro was a new Wolverine Trading position in Q3 2025.
  • ClearPoint Neuro made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4302 holding.
  • Wolverine Trading first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 2 quarters since.
  • Wolverine Trading's ClearPoint Neuro position peaked at $384K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.